Ajanta Pharma (India) Price Prediction
| AJANTPHARM | 2,960 14.55 0.49% |
Oversold Vs Overbought
38
Oversold | Overbought |
Quarterly Earnings Growth 0.114 | EPS Estimate Current Year 82.79 | EPS Estimate Next Year 99.28 | Wall Street Target Price 3 K | EPS Estimate Current Quarter 23.8 |
Using Ajanta Pharma hype-based prediction, you can estimate the value of Ajanta Pharma Limited from the perspective of Ajanta Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ajanta Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ajanta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ajanta Pharma after-hype prediction price | INR 2960.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ajanta |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ajanta Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ajanta Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Ajanta Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ajanta Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ajanta Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ajanta Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ajanta Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ajanta Pharma's historical news coverage. Ajanta Pharma's after-hype downside and upside margins for the prediction period are 2,958 and 2,963, respectively. We have considered Ajanta Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ajanta Pharma is very steady at this time. Analysis and calculation of next after-hype price of Ajanta Pharma Limited is based on 3 months time horizon.
Ajanta Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ajanta Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ajanta Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ajanta Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 2.23 | 0.07 | 0.09 | 12 Events / Month | 2 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2,960 | 2,960 | 0.01 |
|
Ajanta Pharma Hype Timeline
Ajanta Pharma Limited is presently traded for 2,960on National Stock Exchange of India of India. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of 0.09. Ajanta is forecasted to increase in value after the next headline, with the price projected to jump to 2960.28 or above. The average volatility of media hype impact on the company the price is about 59.47%. The price growth on the next news is projected to be 0.01%, whereas the daily expected return is presently at 0.02%. The volatility of related hype on Ajanta Pharma is about 50.06%, with the expected price after the next announcement by competition of 2,960. The company reported the revenue of 42.09 B. Net Income was 8.16 B with profit before overhead, payroll, taxes, and interest of 26.92 B. Assuming the 90 days trading horizon the next forecasted press release will be in about 12 days. Check out Ajanta Pharma Basic Forecasting Models to cross-verify your projections.Ajanta Pharma Related Hype Analysis
Having access to credible news sources related to Ajanta Pharma's direct competition is more important than ever and may enhance your ability to predict Ajanta Pharma's future price movements. Getting to know how Ajanta Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ajanta Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KINGFA | Kingfa Science Technology | (3.75) | 1 per month | 0.00 | (0.17) | 3.60 | (3.65) | 9.31 | |
| RICOAUTO | Rico Auto Industries | 1.13 | 1 per month | 0.00 | (0.28) | 3.21 | (4.52) | 11.81 | |
| GATECHDVR | GACM Technologies Limited | (0.09) | 5 per month | 0.00 | (0.36) | 4.08 | (5.56) | 12.29 | |
| COSMOFIRST | COSMO FIRST LIMITED | (12.20) | 1 per month | 0.00 | (0.16) | 3.02 | (3.92) | 13.96 | |
| TBZ | Tribhovandas Bhimji Zaveri | (3.80) | 3 per month | 3.42 | 0.06 | 10.00 | (5.61) | 27.64 | |
| PARAGMILK | Parag Milk Foods | 13.63 | 4 per month | 2.52 | (0.01) | 5.30 | (4.75) | 12.83 | |
| HEUBACHIND | Heubach Colorants India | 64.90 | 1 per month | 3.21 | (0.01) | 6.95 | (3.00) | 28.86 | |
| CHEMCON | Chemcon Speciality Chemicals | (2.00) | 2 per month | 0.00 | (0.21) | 2.76 | (3.49) | 10.08 | |
| ARVIND | Arvind Limited | (16.80) | 2 per month | 0.00 | (0.08) | 3.34 | (3.29) | 23.01 | |
| LEMONTREE | Lemon Tree Hotels | 3.53 | 3 per month | 0.00 | (0.11) | 2.73 | (3.19) | 9.41 |
Ajanta Pharma Additional Predictive Modules
Most predictive techniques to examine Ajanta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ajanta using various technical indicators. When you analyze Ajanta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ajanta Pharma Predictive Indicators
The successful prediction of Ajanta Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ajanta Pharma Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ajanta Pharma based on analysis of Ajanta Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ajanta Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ajanta Pharma's related companies.
Story Coverage note for Ajanta Pharma
The number of cover stories for Ajanta Pharma depends on current market conditions and Ajanta Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ajanta Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ajanta Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Ajanta Pharma Short Properties
Ajanta Pharma's future price predictability will typically decrease when Ajanta Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ajanta Pharma Limited often depends not only on the future outlook of the potential Ajanta Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ajanta Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 126 M | |
| Cash And Short Term Investments | 4.6 B |
Complementary Tools for Ajanta Stock analysis
When running Ajanta Pharma's price analysis, check to measure Ajanta Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajanta Pharma is operating at the current time. Most of Ajanta Pharma's value examination focuses on studying past and present price action to predict the probability of Ajanta Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajanta Pharma's price. Additionally, you may evaluate how the addition of Ajanta Pharma to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |